TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer

Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer

(2020) Jian Yang et al.   Cell Death & Disease

Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China

(2020) Wanren Peng et al.   Cancer Management and Research

Analysis of the Incidence and Survival of Gastric Cancer Based on the Lauren Classification: A Large Population-Based Study Using SEER

(2020) Chao-Tao Tang et al.   Frontiers in Oncology

Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma

(2020) Suman Verma et al.   BMC CANCER

TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing

(2019) Savli Hakan et al.   JOURNAL OF BIOTECHNOLOGY

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer

(2019) Yan Wang et al.   EBioMedicine

Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing

(2019) Hui Cai et al.   Journal of Translational Medicine

Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma

(2019) Steven B. Maron et al.   CLINICAL CANCER RESEARCH

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

(2019) Aparna R. Parikh et al.   NATURE MEDICINE

ctDNA in Gastric and Gastroesophageal Cancer: Prognostic, Predictive, or Preliminary?

(2019) Alexander M. Frankell et al.   CLINICAL CANCER RESEARCH

Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China

(2019) Lin Zhao et al.   Frontiers in Oncology

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

(2018) Sadakatsu Ikeda et al.   Journal of Hematology & Oncology

MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis

(2018) Han S. Kim et al.   JOURNAL OF SURGICAL ONCOLOGY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors

(2018) Taryn D. Treger et al.   Translational Oncology

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing

(2016) Chiaki Nakauchi et al.   Clinical Breast Cancer

The challenge of screening for early gastric cancer in China

(2016) Liang Zong et al.   LANCET

Gastric biomarkers: a global review

(2016) Nick Baniak et al.   World Journal of Surgical Oncology

Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence

(2016) Masami Ueda et al.   Oncotarget

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

(2016) Christine A. Parkinson et al.   PLOS MEDICINE

High-fidelity target sequencing of individual molecules identified using barcode sequences:de novodetection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients

(2015) Yoji Kukita et al.   DNA RESEARCH

Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy

(2015) Kexin Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Monitoring gastric cancer progression with circulating tumour DNA

(2014) T Hamakawa et al.   BRITISH JOURNAL OF CANCER

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis

(2014) Zhi Peng et al.   PLoS One

Genetic Mutation Analysis of Human Gastric Adenocarcinomas Using Ion Torrent Sequencing Platform

(2014) Zhi Xu et al.   PLoS One

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

(2014) Swee Seong Wong et al.   Nature Communications

METamplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy

(2013) Xin An et al.   CANCER

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients

(2013) Diego M Marzese et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Alterations of theTP53Gene in Gastric and Esophageal Carcinogenesis

(2012) Marilanda Ferreira Bellini et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

p53: The Attractive Tumor Suppressor in the Cancer Research Field

(2010) Toshinori Ozaki et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Advances in understanding cancer genomes through second-generation sequencing

(2010) Matthew Meyerson et al.   NATURE REVIEWS GENETICS

p53 Research: The Past Thirty Years and the Next Thirty Years

(2010) D. Lane et al.   Cold Spring Harbor Perspectives in Biology

Sequencing technologies — the next generation

(2009) Michael L. Metzker   NATURE REVIEWS GENETICS